Interferon Beta-1b Effective, Safe for Older MS Patients: Real-world Study

Interferon Beta-1b Effective, Safe for Older MS Patients: Real-world Study

304658

Interferon Beta-1b Effective, Safe for Older MS Patients: Real-world Study

A real-world study confirmed the effectiveness and safety of interferon beta-1b in treating older adults with multiple sclerosis (MS), those over the age of 40. “These findings from a real-world setting are promising and demonstrate the positive benefit-risk ratio for [interferon beta-1b] in this study population of middle-aged and older MS patients,” the researchers wrote. The study, “Clinical characteristics of middle-aged and older patients with MS treated with interferon beta-1b: post-hoc analysis of a 2-year,…

You must be logged in to read/download the full post.